Skip to main content
PMC home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1997 Oct 15;25(20):4111–4116. doi: 10.1093/nar/25.20.4111

In vivo sequencing of camptothecin-induced topoisomerase I cleavage sites in human colon carcinoma cells.

C Pondarré 1, D Strumberg 1, A Fujimori 1, R Torres-León 1, Y Pommier 1
PMCID: PMC147024  PMID: 9321666

Abstract

Camptothecin (CPT) is a specific topoisomerase I (top1) poison which traps top1 cleavable complexes; e.g. top1-linked DNA single-strand breaks with 5'-hydroxyl and 3'-top1 linked termini. CPT is also a potent anticancer agent and several of its derivatives have recently shown activity in the chemotherapy of solid tumors. Our aim was to apply the ligation-mediated polymerase chain reaction (LM-PCR) method to DNA extracted from CPT-treated cells in order to: (i) evaluate LM-PCR as a sensitive technique to detect in vivo CPT-induced cleavable complexes; (ii) investigate the frequency and distribution of CPT-induced DNA damage in vivo ; and (iii) compare the distribution and intensity of cleavage sites in vivo and in vitro. This report describes a protocol allowing the sequencing of top1-mediated DNA strand breaks induced by CPT in the coding strand of the 18S rRNA gene of human colon carcinoma cells. CPT or its clinical derivatives, topotecan, CPT-11, SN-38, and 9-aminocamptothecin differed in their potency and exhibited differences in their DNA cleavage pattern, which is consistent with our previous in vitro studies [Tanizawa et al . (1995) Biochemistry , 43, 7200-7206]. CPT-induced DNA cleavages induced in the presence of purified top1 were induced at the same sites in the human 18S rDNA. However, the relative intensity of the cleavages were different in vivo and in vitro. Because mammalian cells contain approximately 300 copies of the rDNA gene per genome, rDNA could be used to monitor CPT-induced DNA cleavage in different cell lines and possibly in tumor samples.

Full Text

The Full Text of this article is available as a PDF (164.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bronstein I. B., Gromova I. I., Razin S. V. Specific cleavage of chicken alpha A-globin and human c-Ha-ras genes by two molecular forms of calf thymus topoisomerase I. Mol Cell Biochem. 1991 Mar 13;101(2):115–124. doi: 10.1007/BF00229529. [DOI] [PubMed] [Google Scholar]
  2. Covey J. M., Jaxel C., Kohn K. W., Pommier Y. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Cancer Res. 1989 Sep 15;49(18):5016–5022. [PubMed] [Google Scholar]
  3. Culotta V., Sollner-Webb B. Sites of topoisomerase I action on X. laevis ribosomal chromatin: transcriptionally active rDNA has an approximately 200 bp repeating structure. Cell. 1988 Feb 26;52(4):585–597. doi: 10.1016/0092-8674(88)90471-0. [DOI] [PubMed] [Google Scholar]
  4. Garg L. C., DiAngelo S., Jacob S. T. Role of DNA topoisomerase I in the transcription of supercoiled rRNA gene. Proc Natl Acad Sci U S A. 1987 May;84(10):3185–3188. doi: 10.1073/pnas.84.10.3185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gilmour D. S., Elgin S. C. Localization of specific topoisomerase I interactions within the transcribed region of active heat shock genes by using the inhibitor camptothecin. Mol Cell Biol. 1987 Jan;7(1):141–148. doi: 10.1128/mcb.7.1.141. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Goldwasser F., Bae I., Valenti M., Torres K., Pommier Y. Topoisomerase I-related parameters and camptothecin activity in the colon carcinoma cell lines from the National Cancer Institute anticancer screen. Cancer Res. 1995 May 15;55(10):2116–2121. [PubMed] [Google Scholar]
  7. Gupta M., Fujimori A., Pommier Y. Eukaryotic DNA topoisomerases I. Biochim Biophys Acta. 1995 May 17;1262(1):1–14. doi: 10.1016/0167-4781(95)00029-g. [DOI] [PubMed] [Google Scholar]
  8. Hsiang Y. H., Hertzberg R., Hecht S., Liu L. F. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem. 1985 Nov 25;260(27):14873–14878. [PubMed] [Google Scholar]
  9. Hsiang Y. H., Liu L. F. Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res. 1988 Apr 1;48(7):1722–1726. [PubMed] [Google Scholar]
  10. Jaxel C., Capranico G., Kerrigan D., Kohn K. W., Pommier Y. Effect of local DNA sequence on topoisomerase I cleavage in the presence or absence of camptothecin. J Biol Chem. 1991 Oct 25;266(30):20418–20423. [PubMed] [Google Scholar]
  11. Kjeldsen E., Mollerup S., Thomsen B., Bonven B. J., Bolund L., Westergaard O. Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage. J Mol Biol. 1988 Jul 20;202(2):333–342. doi: 10.1016/0022-2836(88)90462-7. [DOI] [PubMed] [Google Scholar]
  12. Kohn K. W. Principles and practice of DNA filter elution. Pharmacol Ther. 1991;49(1-2):55–77. doi: 10.1016/0163-7258(91)90022-e. [DOI] [PubMed] [Google Scholar]
  13. Kroeger P. E., Rowe T. C. Analysis of topoisomerase I and II cleavage sites on the Drosophila actin and Hsp70 heat shock genes. Biochemistry. 1992 Mar 10;31(9):2492–2501. doi: 10.1021/bi00124a008. [DOI] [PubMed] [Google Scholar]
  14. Leteurtre F., Fujimori A., Tanizawa A., Chhabra A., Mazumder A., Kohlhagen G., Nakano H., Pommier Y. Saintopin, a dual inhibitor of DNA topoisomerases I and II, as a probe for drug-enzyme interactions. J Biol Chem. 1994 Nov 18;269(46):28702–28707. [PubMed] [Google Scholar]
  15. Leteurtre F., Kohlhagen G., Fesen M. R., Tanizawa A., Kohn K. W., Pommier Y. Effects of DNA methylation on topoisomerase I and II cleavage activities. J Biol Chem. 1994 Mar 18;269(11):7893–7900. [PubMed] [Google Scholar]
  16. Pfeifer G. P., Steigerwald S. D., Mueller P. R., Wold B., Riggs A. D. Genomic sequencing and methylation analysis by ligation mediated PCR. Science. 1989 Nov 10;246(4931):810–813. doi: 10.1126/science.2814502. [DOI] [PubMed] [Google Scholar]
  17. Pommier Y., Leteurtre F., Fesen M. R., Fujimori A., Bertrand R., Solary E., Kohlhagen G., Kohn K. W. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Invest. 1994;12(5):530–542. doi: 10.3109/07357909409021413. [DOI] [PubMed] [Google Scholar]
  18. Pommier Y., Poddevin B., Gupta M., Jenkins J. DNA topoisomerases I & II cleavage sites in the type 1 human immunodeficiency virus (HIV-1) DNA promoter region. Biochem Biophys Res Commun. 1994 Dec 30;205(3):1601–1609. doi: 10.1006/bbrc.1994.2850. [DOI] [PubMed] [Google Scholar]
  19. Porter S. E., Champoux J. J. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. Nucleic Acids Res. 1989 Nov 11;17(21):8521–8532. doi: 10.1093/nar/17.21.8521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stewart A. F., Herrera R. E., Nordheim A. Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities. Cell. 1990 Jan 12;60(1):141–149. doi: 10.1016/0092-8674(90)90724-s. [DOI] [PubMed] [Google Scholar]
  21. Stewart A. F., Schütz G. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene. Cell. 1987 Sep 25;50(7):1109–1117. doi: 10.1016/0092-8674(87)90177-2. [DOI] [PubMed] [Google Scholar]
  22. Svejstrup J. Q., Christiansen K., Gromova I. I., Andersen A. H., Westergaard O. New technique for uncoupling the cleavage and religation reactions of eukaryotic topoisomerase I. The mode of action of camptothecin at a specific recognition site. J Mol Biol. 1991 Dec 5;222(3):669–678. doi: 10.1016/0022-2836(91)90503-x. [DOI] [PubMed] [Google Scholar]
  23. Sylvester J. E., Whiteman D. A., Podolsky R., Pozsgay J. M., Respess J., Schmickel R. D. The human ribosomal RNA genes: structure and organization of the complete repeating unit. Hum Genet. 1986 Jul;73(3):193–198. doi: 10.1007/BF00401226. [DOI] [PubMed] [Google Scholar]
  24. Tanizawa A., Kohn K. W., Kohlhagen G., Leteurtre F., Pommier Y. Differential stabilization of eukaryotic DNA topoisomerase I cleavable complexes by camptothecin derivatives. Biochemistry. 1995 May 30;34(21):7200–7206. doi: 10.1021/bi00021a035. [DOI] [PubMed] [Google Scholar]
  25. Tanizawa A., Kohn K. W., Pommier Y. Induction of cleavage in topoisomerase I c-DNA by topoisomerase I enzymes from calf thymus and wheat germ in the presence and absence of camptothecin. Nucleic Acids Res. 1993 Nov 11;21(22):5157–5166. doi: 10.1093/nar/21.22.5157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Trask D. K., DiDonato J. A., Muller M. T. Rapid detection and isolation of covalent DNA/protein complexes: application to topoisomerase I and II. EMBO J. 1984 Mar;3(3):671–676. doi: 10.1002/j.1460-2075.1984.tb01865.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wang J. C. DNA topoisomerases. Annu Rev Biochem. 1996;65:635–692. doi: 10.1146/annurev.bi.65.070196.003223. [DOI] [PubMed] [Google Scholar]
  28. Zhang H., Wang J. C., Liu L. F. Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1060–1064. doi: 10.1073/pnas.85.4.1060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Zhelkovsky A. M., Moore C. L. Overexpression of human DNA topoisomerase I in insect cells using a baculovirus vector. Protein Expr Purif. 1994 Aug;5(4):364–370. doi: 10.1006/prep.1994.1053. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES